Centessa Pharmaceuticals plc (CNTA)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 9.16 |
| Open | 9.17 |
| Bid | 9.42 x 100 |
| Ask | 9.51 x 200 |
| Day's range | 8.98 - 9.64 |
| 52-week range | 3.96 - 12.45 |
| Volume | |
| Avg. volume | 381,967 |
| Market cap | 1.053B |
| Beta (5Y monthly) | 1.38 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GuruFocus.com
Centessa Pharmaceuticals PLC (CNTA) Earnings: A Detailed Look at Q4 and Full-Year 2023 Results
Aligning with EPS Projections, CNTA Reports a Net Loss Decrease in Q4
- GuruFocus.com
Centessa Pharmaceuticals PLC Chief People Officer Sells Company Shares
Karen Anderson, the Chief People Officer of Centessa Pharmaceuticals PLC (NASDAQ:CNTA), has sold 51,160 shares of the company on March 25, 2024, according to a recent SEC Filing.
- Simply Wall St.
Private equity firms who have a significant stake must be disappointed along with institutions after Centessa Pharmaceuticals plc's (NASDAQ:CNTA) market cap dropped by US$139m
Key Insights The considerable ownership by private equity firms in Centessa Pharmaceuticals indicates that they...
© 2024 Yahoo. All rights reserved.